Veterinary Medicines

Eurican DAP – LR liofilizāts un suspensija suspensijas injekcijām pagatavošanai suņiem

Not authorised
  • Canine distemper virus, strain BA5, Live
  • Canine adenovirus 2, strain DK13, Live
  • Canine parvovirus, strain CAG2, Live
  • Leptospira interrogans, serovar Canicola, strain 16070, Inactivated
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 16069, Inactivated
  • Rabies virus, strain G52, Inactivated
Download as PDF

Product identification

Medicine name:
Eurican DAP – LR liofilizāts un suspensija suspensijas injekcijām pagatavošanai suņiem
Active substance:
  • Canine distemper virus, strain BA5, Live
  • Canine adenovirus 2, strain DK13, Live
  • Canine parvovirus, strain CAG2, Live
  • Leptospira interrogans, serovar Canicola, strain 16070, Inactivated
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 16069, Inactivated
  • Rabies virus, strain G52, Inactivated
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine distemper virus, strain BA5, Live
    10000.00
    50% cell culture infectious dose
    /
    1.00
    Dose
  • Canine adenovirus 2, strain DK13, Live
    316.23
    50% cell culture infectious dose
    /
    1.00
    Dose
  • Canine parvovirus, strain CAG2, Live
    79432.80
    50% cell culture infectious dose
    /
    1.00
    Dose
  • Leptospira interrogans, serovar Canicola, strain 16070, Inactivated
    1.00
    Hamster protective Dose 80%
    /
    1.00
    Dose
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 16069, Inactivated
    1.00
    Hamster protective Dose 80%
    /
    1.00
    Dose
  • Rabies virus, strain G52, Inactivated
    1.00
    international unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and suspension for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AI03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/NRP/95/0197
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 21/03/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 21/03/2024
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 21/03/2024
Download